The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children,
Adolescents, and Young Adults With B-acute lymphoblastic leukemia (ALL)
Is not providing total body irradiation in B cell ALL patients effective before the
patient receives a stem cell transplant?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
This study will evaluate the use of non- TBI (total body irradiation) conditioning
for B-ALL patients with low risk of relapse as defined by the lack of residual disease
(NGS-MRD before receiving a hematopoietic cell transplant (HCT). Patients diagnosed
with B-ALL who are candidates for a transplant will be screened on a test of bone
marrow done before the transplant.
Study Reference #: PLEU19018
Lead Researcher (Principal Investigator)
Study Contact InformationStudy Coordinator: Haley Misch
Phone: (585) 275-9485
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search